T. Rowe Price Associates’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $918K | Buy |
16,118
+648
| +4% | +$36.9K | ﹤0.01% | 2018 |
|
2025
Q1 | $868K | Buy |
15,470
+257
| +2% | +$14.4K | ﹤0.01% | 2026 |
|
2024
Q4 | $936K | Sell |
15,213
-7,227
| -32% | -$445K | ﹤0.01% | 1992 |
|
2024
Q3 | $1.5M | Sell |
22,440
-1,501
| -6% | -$100K | ﹤0.01% | 1775 |
|
2024
Q2 | $1.6M | Buy |
23,941
+1,000
| +4% | +$66.8K | ﹤0.01% | 1674 |
|
2024
Q1 | $1.63M | Buy |
22,941
+947
| +4% | +$67.4K | ﹤0.01% | 1676 |
|
2023
Q4 | $1.85M | Sell |
21,994
-1,979
| -8% | -$167K | ﹤0.01% | 1573 |
|
2023
Q3 | $2.06M | Buy |
23,973
+857
| +4% | +$73.7K | ﹤0.01% | 1447 |
|
2023
Q2 | $2.16M | Buy |
23,116
+56
| +0.2% | +$5.22K | ﹤0.01% | 1445 |
|
2023
Q1 | $2.19M | Buy |
23,060
+22
| +0.1% | +$2.09K | ﹤0.01% | 1432 |
|
2022
Q4 | $2.32M | Buy |
23,038
+73
| +0.3% | +$7.34K | ﹤0.01% | 1415 |
|
2022
Q3 | $1.96M | Sell |
22,965
-341,547
| -94% | -$29.2M | ﹤0.01% | 1461 |
|
2022
Q2 | $31.3M | Sell |
364,512
-700
| -0.2% | -$60.1K | ﹤0.01% | 1032 |
|
2022
Q1 | $32.8M | Buy |
365,212
+22,537
| +7% | +$2.03M | ﹤0.01% | 1097 |
|
2021
Q4 | $34.3M | Buy |
342,675
+61,290
| +22% | +$6.13M | ﹤0.01% | 1132 |
|
2021
Q3 | $26.1M | Sell |
281,385
-245
| -0.1% | -$22.7K | ﹤0.01% | 1229 |
|
2021
Q2 | $24M | Buy |
281,630
+1,735
| +0.6% | +$148K | ﹤0.01% | 1256 |
|
2021
Q1 | $24.2M | Sell |
279,895
-233
| -0.1% | -$20.2K | ﹤0.01% | 1226 |
|
2020
Q4 | $23.6M | Sell |
280,128
-19
| -0% | -$1.6K | ﹤0.01% | 1179 |
|
2020
Q3 | $22.4M | Sell |
280,147
-13,360
| -5% | -$1.07M | ﹤0.01% | 1124 |
|
2020
Q2 | $26M | Sell |
293,507
-5,115
| -2% | -$453K | ﹤0.01% | 1063 |
|
2020
Q1 | $28.1M | Sell |
298,622
-20,061
| -6% | -$1.89M | ﹤0.01% | 959 |
|
2019
Q4 | $34.4M | Sell |
318,683
-7,874
| -2% | -$850K | ﹤0.01% | 1030 |
|
2019
Q3 | $31.3M | Buy |
326,557
+893
| +0.3% | +$85.6K | ﹤0.01% | 1019 |
|
2019
Q2 | $31.2M | Buy |
325,664
+9,510
| +3% | +$910K | ﹤0.01% | 1033 |
|
2019
Q1 | $27.9M | Buy |
316,154
+23,562
| +8% | +$2.08M | ﹤0.01% | 1070 |
|
2018
Q4 | $24.3M | Buy |
292,592
+947
| +0.3% | +$78.7K | ﹤0.01% | 1087 |
|
2018
Q3 | $27.5M | Buy |
291,645
+61
| +0% | +$5.75K | ﹤0.01% | 1114 |
|
2018
Q2 | $32.1M | Buy |
291,584
+1,913
| +0.7% | +$211K | ﹤0.01% | 1043 |
|
2018
Q1 | $28.6M | Buy |
289,671
+109
| +0% | +$10.8K | ﹤0.01% | 1057 |
|
2017
Q4 | $23.6M | Sell |
289,562
-8,996
| -3% | -$732K | ﹤0.01% | 1126 |
|
2017
Q3 | $22M | Sell |
298,558
-4,400
| -1% | -$324K | ﹤0.01% | 1139 |
|
2017
Q2 | $21.9M | Buy |
302,958
+1,100
| +0.4% | +$79.6K | ﹤0.01% | 1142 |
|
2017
Q1 | $18.8M | Sell |
301,858
-3,161
| -1% | -$197K | ﹤0.01% | 1186 |
|
2016
Q4 | $22.2M | Hold |
305,019
| – | – | ﹤0.01% | 1105 |
|
2016
Q3 | $18.2M | Buy |
305,019
+219
| +0.1% | +$13.1K | ﹤0.01% | 1166 |
|
2016
Q2 | $19.2M | Buy |
304,800
+600
| +0.2% | +$37.8K | ﹤0.01% | 1115 |
|
2016
Q1 | $19M | Buy |
304,200
+900
| +0.3% | +$56.3K | ﹤0.01% | 1097 |
|
2015
Q4 | $17.8M | Sell |
303,300
-16,140
| -5% | -$945K | ﹤0.01% | 1122 |
|
2015
Q3 | $17.2M | Buy |
319,440
+600
| +0.2% | +$32.3K | ﹤0.01% | 1142 |
|
2015
Q2 | $19M | Buy |
318,840
+450
| +0.1% | +$26.8K | ﹤0.01% | 1153 |
|
2015
Q1 | $19.1M | Buy |
318,390
+850
| +0.3% | +$50.9K | ﹤0.01% | 1146 |
|
2014
Q4 | $19.1M | Buy |
317,540
+100
| +0% | +$6.01K | ﹤0.01% | 1126 |
|
2014
Q3 | $15.5M | Buy |
317,440
+250
| +0.1% | +$12.2K | ﹤0.01% | 1184 |
|
2014
Q2 | $16.3M | Buy |
317,190
+31,787
| +11% | +$1.64M | ﹤0.01% | 1172 |
|
2014
Q1 | $16.5M | Buy |
285,403
+5,247
| +2% | +$303K | ﹤0.01% | 1167 |
|
2013
Q4 | $16M | Buy |
280,156
+37,414
| +15% | +$2.14M | ﹤0.01% | 1156 |
|
2013
Q3 | $14.4M | Buy |
242,742
+28,926
| +14% | +$1.72M | ﹤0.01% | 1171 |
|
2013
Q2 | $11.6M | Buy |
+213,816
| New | +$11.6M | ﹤0.01% | 1205 |
|